SMTL ID : 3ld6.2 (1 other biounit)

Crystal structure of human lanosterol 14alpha-demethylase (CYP51) in complex with ketoconazole

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

homo-dimer

Ligands

2 x GLC- GLC- GLC- GLC- GLC- GLC- GLC: Cycloheptakis-(1-4)-(alpha-D-glucopyranose)(Non-covalent)

GLC-GLC-GLC-GLC-GLC-GLC-GLC.1: 14 residues within 4Å: Chain A: P.13, P.14, Y.15, I.16, F.17, S.18, P.19, Y.44 Chain B: D.81, M.335, A.336, R.337, P.349, G.350 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.18 GLC-GLC-GLC-GLC-GLC-GLC-GLC.4: 13 residues within 4Å: Chain A: D.81, M.335, A.336, R.337, P.349, G.350 Chain B: P.13, P.14, Y.15, I.16, F.17, S.18, Y.44 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:S.18

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.2: 24 residues within 4Å: Chain A: Y.83, Y.97, F.104, K.108, L.115, L.260, A.263, G.264, T.267, P.328, I.329, M.332, R.334, P.393, F.394, G.395, H.399, R.400, C.401, I.402, G.403, F.406, A.407 Ligands: KKK.3 16 PLIP interactions: 16 interactions with chain A, Hydrophobic interactions: A:F.104, A:L.115, A:L.260, A:P.328, A:I.329, A:F.394, A:I.402, A:F.406, A:A.407 Hydrogen bonds: A:Y.83, A:Y.97, A:H.399 Salt bridges: A:K.108, A:R.334, A:H.399 Metal complexes: A:C.401 HEM.5: 24 residues within 4Å: Chain B: Y.83, Y.97, F.104, K.108, L.115, L.260, A.263, G.264, T.267, L.323, P.328, I.329, M.332, R.334, P.393, F.394, G.395, H.399, C.401, I.402, G.403, F.406, A.407 Ligands: KKK.6 17 PLIP interactions: 17 interactions with chain B, Hydrophobic interactions: B:F.104, B:L.115, B:L.260, B:P.328, B:I.329, B:I.329, B:F.394, B:I.402, B:F.406, B:A.407 Hydrogen bonds: B:Y.97, B:Y.97, B:H.399 Salt bridges: B:K.108, B:R.334, B:H.399 Metal complexes: B:C.401

2 x KKK: 1-acetyl-4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine(Non-covalent)

KKK.3: 15 residues within 4Å: Chain A: F.29, Y.83, L.86, F.91, Y.97, F.186, W.191, G.259, A.263, T.267, I.329, I.331, M.333, M.439 Ligands: HEM.2 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Y.83, A:L.86, A:F.91, A:W.191, A:A.263 Hydrogen bonds: A:Y.97 KKK.6: 15 residues within 4Å: Chain B: F.29, F.57, Y.83, F.91, Y.97, F.186, W.191, G.259, A.263, T.267, I.329, I.331, M.333, M.439 Ligands: HEM.5 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:F.57, B:Y.83, B:F.91, B:W.191, B:A.263

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Strushkevich, N. et al., Structural basis of human CYP51 inhibition by antifungal azoles. J.Mol.Biol. (2010)

Release Date

2010-02-02

Peptides

Lanosterol 14-alpha demethylase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Lanosterol 14-alpha demethylase

Related Entries With Identical Sequence